Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion?

The aim of this study was to investigate the feasibility, safety, and efficacy of Mitraclip therapy in patients with functional mitral regurgitation (MR) and missing leaflet coaptation (MLC).

[1]  D. Burkhoff,et al.  Long-term survival after MitraClip(®) therapy in patients with severe mitral regurgitation and severe congestive heart failure: A comparison among survivals predicted by heart failure models. , 2016, Journal of cardiology.

[2]  A. Triantafyllis,et al.  Long‐term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  G. Filippatos,et al.  Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.

[4]  H. Ince,et al.  Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. , 2015, The American journal of cardiology.

[5]  D. Capodanno,et al.  Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. , 2015, American heart journal.

[6]  M. Metra,et al.  Effectiveness of MitraClip therapy in patients with refractory heart failure. , 2015, Journal of interventional cardiology.

[7]  D. Capodanno,et al.  Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. , 2015, JACC. Cardiovascular interventions.

[8]  Antonio Colombo,et al.  Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  S. Blankenberg,et al.  Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. , 2014, Journal of the American College of Cardiology.

[10]  S. Blankenberg,et al.  MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome. , 2014, JACC. Cardiovascular interventions.

[11]  Patric Biaggi,et al.  Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome , 2014, Open Heart.

[12]  Christian Butter,et al.  Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system , 2014, Clinical Research in Cardiology.

[13]  R. Siegel,et al.  Peri-interventional echo assessment for the MitraClip procedure. , 2013, European heart journal cardiovascular Imaging.

[14]  J. Hausleiter,et al.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. , 2013, Journal of the American College of Cardiology.

[15]  E. Foster,et al.  4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. , 2013, Journal of the American College of Cardiology.

[16]  S. Blankenberg,et al.  Aetiology of mitral regurgitation differentially affects 2‐year adverse outcomes after MitraClip therapy in high‐risk patients , 2013, European journal of heart failure.

[17]  D. Capodanno,et al.  One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). , 2013, The American journal of cardiology.

[18]  C. Nienaber,et al.  Use of four MitraClip devices in a patient with ischemic cardiomyopathy and mitral regurgitation , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[20]  Juerg Schwitter,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[21]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[22]  K. Kuck,et al.  MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry , 2012, European journal of heart failure.

[23]  Hiroyuki Okura,et al.  Influence of chronic tethering of the mitral valve on mitral leaflet size and coaptation in functional mitral regurgitation. , 2012, JACC. Cardiovascular imaging.

[24]  Falk,et al.  Kommentar zu den gemeinsamen "Guidelines on myocardial revascularization" der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) , 2012, Zeitschrift für Herz-,Thorax- und Gefäßchirurgie.

[25]  T. Meinertz,et al.  MitraClip® therapy in patients with end‐stage systolic heart failure , 2011, European journal of heart failure.

[26]  J. Gorman,et al.  Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.

[27]  Laura Mauri,et al.  The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. , 2010, American heart journal.

[28]  H. Reichenspurner,et al.  Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. , 2010, European heart journal.

[29]  G. Filippatos,et al.  [Guidelines on the management of valvular heart disease]. , 2013, Revista espanola de cardiologia.

[30]  E. Foster,et al.  Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. , 2007, The American journal of cardiology.

[31]  J. Mirelis,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[32]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .